COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 165 filers reported holding COHERUS BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $83 | -50.0% | 22,127 | -43.0% | 0.00% | – |
| Q2 2023 | $166 | -35.2% | 38,786 | +3.9% | 0.00% | – |
| Q1 2023 | $256 | -20.7% | 37,342 | -8.3% | 0.00% | – |
| Q4 2022 | $323 | -99.9% | 40,721 | -27.0% | 0.00% | – |
| Q3 2022 | $537,000 | +44.4% | 55,776 | +8.7% | 0.00% | – |
| Q2 2022 | $372,000 | -24.8% | 51,329 | +33.9% | 0.00% | – |
| Q1 2022 | $495,000 | -16.0% | 38,334 | +3.8% | 0.00% | – |
| Q4 2021 | $589,000 | -3.8% | 36,934 | -3.0% | 0.00% | – |
| Q3 2021 | $612,000 | +17.0% | 38,078 | +0.7% | 0.00% | – |
| Q2 2021 | $523,000 | -2.1% | 37,810 | +3.5% | 0.00% | – |
| Q1 2021 | $534,000 | -64.7% | 36,526 | -58.0% | 0.00% | – |
| Q4 2020 | $1,511,000 | -5.4% | 86,945 | -0.2% | 0.00% | – |
| Q3 2020 | $1,598,000 | +74.5% | 87,155 | +70.0% | 0.00% | – |
| Q2 2020 | $916,000 | -13.3% | 51,280 | -21.3% | 0.00% | – |
| Q1 2020 | $1,057,000 | -14.6% | 65,154 | -5.2% | 0.00% | – |
| Q4 2019 | $1,238,000 | -7.7% | 68,743 | +3.8% | 0.00% | – |
| Q3 2019 | $1,342,000 | -10.8% | 66,250 | -2.7% | 0.00% | – |
| Q2 2019 | $1,505,000 | -77.7% | 68,115 | -86.2% | 0.00% | -100.0% |
| Q1 2019 | $6,741,000 | -9.6% | 494,219 | -40.0% | 0.00% | 0.0% |
| Q4 2018 | $7,454,000 | -64.5% | 823,661 | -35.3% | 0.00% | -66.7% |
| Q3 2018 | $21,010,000 | -12.5% | 1,273,319 | -25.8% | 0.00% | -25.0% |
| Q2 2018 | $24,009,000 | +45.6% | 1,714,956 | +14.9% | 0.00% | +33.3% |
| Q1 2018 | $16,488,000 | +103.8% | 1,492,099 | +62.3% | 0.00% | +200.0% |
| Q4 2017 | $8,089,000 | -50.0% | 919,202 | -24.1% | 0.00% | -66.7% |
| Q3 2017 | $16,173,000 | +64.9% | 1,211,472 | +77.3% | 0.00% | +50.0% |
| Q2 2017 | $9,808,000 | -42.5% | 683,452 | -15.2% | 0.00% | -33.3% |
| Q1 2017 | $17,054,000 | -28.3% | 806,346 | -4.6% | 0.00% | -40.0% |
| Q4 2016 | $23,782,000 | +6.8% | 844,832 | +1.6% | 0.01% | +25.0% |
| Q3 2016 | $22,263,000 | – | 831,322 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |